Video

Dr. Giaconne on the Lack of Funding for Rare Cancers Research

Giuseppe Giaccone, MD, PhD, highlights the difficulties with funding for research focused on rare cancers.

Giuseppe Giaccone, MD, PhD, is a professor of medicine and associate director of clinical research at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine in New York, New York.

As is the case with many rare cancers, investigators struggle to find funding to research thymic cancers. On one level, Giaccone understands that there will be less funding available when compared with a malignancy such as breast cancer. However, for patients with thymic cancer, this reach is absolutely vital.

The Department of Defense and small foundations make some funding available. However, Giaccone would like to see the federal government take a more proactive role in making money available for this resarch.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center